BIO-MATRIX SCIENTIFIC GROUP INC (OTCMKTS:BMSN) Shorted Shares Increased 21.6% After Market Selling

May 18, 2018 - By Ned Sandoval

The stock of BIO-MATRIX SCIENTIFIC GROUP INC (OTCMKTS:BMSN) registered an increase of 21.6% in short interest. BMSN’s total short interest was 243,200 shares in May as published by FINRA. Its up 21.6% from 200,000 shares, reported previously. With 2.40 million shares average volume, it will take short sellers 0 days to cover their BMSN’s short positions.

It closed at $0.0001 lastly. It is down 0.00% since May 18, 2017 and is . It has underperformed by 11.55% the S&P500.

Bio-Matrix Scientific Group, Inc., through its subsidiary, Regen BioPharma, Inc., intends to engage primarily in the development of regenerative medical applications. The company has market cap of $695,685. The firm develops HemaXellerate I, a patient-specific composition of cells that have been demonstrated to repair damaged bone marrow and stimulate production of blood cells based on previous animal studies; and HemaXellerate II, an early stage development product for stimulating bone marrow hematopoetic stem cell repair and proliferation. It currently has negative earnings. It also develops dCellVax, an early stage development product that is intended to treat dendritic cells of the cancer patient using plasmid DNA; NR2F6, a research project to treat myelodysplastic syndrome; and Tcellvax, an autologous cellular product.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: